Literature DB >> 18768698

Nucleus accumbens adenosine A2A receptors regulate exertion of effort by acting on the ventral striatopallidal pathway.

Susana Mingote1, Laura Font, Andrew M Farrar, Regina Vontell, Lila T Worden, Colin M Stopper, Russell G Port, Kelly S Sink, Jamie G Bunce, James J Chrobak, John D Salamone.   

Abstract

Goal-directed actions are sensitive to work-related response costs, and dopamine in nucleus accumbens is thought to modulate the exertion of effort in motivated behavior. Dopamine-rich striatal areas such as nucleus accumbens also contain high numbers of adenosine A(2A) receptors, and, for that reason, the behavioral and neurochemical effects of the adenosine A(2A) receptor agonist CGS 21680 [2-p-(2-carboxyethyl) phenethylamino-5'-N-ethylcarboxamidoadenosine] were investigated. Stimulation of accumbens adenosine A(2A) receptors disrupted performance of an instrumental task with high work demands (i.e., an interval lever-pressing schedule with a ratio requirement attached) but had little effect on a task with a lower work requirement. Immunohistochemical studies revealed that accumbens neurons that project to the ventral pallidum showed adenosine A(2A) receptors immunoreactivity. Moreover, activation of accumbens A(2A) receptors by local injections of CGS 21680 increased extracellular GABA levels in the ventral pallidum. Combined contralateral injections of CGS 21680 into the accumbens and the GABA(A) agonist muscimol into ventral pallidum (i.e., "disconnection" methods) also impaired response output, indicating that these structures are part of a common neural circuitry regulating the exertion of effort. Thus, accumbens adenosine A(2A) receptors appear to regulate behavioral activation and effort-related processes by modulating the activity of the ventral striatopallidal pathway. Research on the effort-related functions of these forebrain systems may lead to a greater understanding of pathological features of motivation, such as psychomotor slowing, anergia, and fatigue in depression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18768698      PMCID: PMC2806668          DOI: 10.1523/JNEUROSCI.1525-08.2008

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  66 in total

1.  Systemic administration of adenosine A(2A) receptor antagonist reverses increased GABA release in the globus pallidus of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study.

Authors:  M Ochi; K Koga; M Kurokawa; H Kase; J Nakamura; Y Kuwana
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

2.  Injections of the selective adenosine A2A antagonist MSX-3 into the nucleus accumbens core attenuate the locomotor suppression induced by haloperidol in rats.

Authors:  Keita Ishiwari; Lisa J Madson; Andrew M Farrar; Susana M Mingote; John P Valenta; Michael D DiGianvittorio; Lauren E Frank; Merce Correa; Jörg Hockemeyer; Christa Müller; John D Salamone
Journal:  Behav Brain Res       Date:  2006-12-21       Impact factor: 3.332

Review 3.  Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits.

Authors:  J D Salamone; M Correa; A Farrar; S M Mingote
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

Review 4.  Adenosine A(2A) receptors, dopamine D(2) receptors and their interactions in Parkinson's disease.

Authors:  Kjell Fuxe; Daniel Marcellino; Susanna Genedani; Luigi Agnati
Journal:  Mov Disord       Date:  2007-10-31       Impact factor: 10.338

Review 5.  Adenosine A2A receptors and basal ganglia physiology.

Authors:  S N Schiffmann; G Fisone; R Moresco; R A Cunha; S Ferré
Journal:  Prog Neurobiol       Date:  2007-06-26       Impact factor: 11.685

6.  General and outcome-specific forms of Pavlovian-instrumental transfer: the effect of shifts in motivational state and inactivation of the ventral tegmental area.

Authors:  Laura H Corbit; Patricia H Janak; Bernard W Balleine
Journal:  Eur J Neurosci       Date:  2007-11-14       Impact factor: 3.386

7.  Adenosine A(2A) receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowing.

Authors:  Andrew M Farrar; Mariana Pereira; Francisco Velasco; Jörg Hockemeyer; Christa E Müller; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2006-10-27       Impact factor: 4.530

Review 8.  Role of adenosine A2A receptors in parkinsonian motor impairment and l-DOPA-induced motor complications.

Authors:  Micaela Morelli; Therese Di Paolo; Jadwiga Wardas; Frederic Calon; Danqing Xiao; Michael A Schwarzschild
Journal:  Prog Neurobiol       Date:  2007-07-27       Impact factor: 11.685

9.  Intra-accumbens injections of the adenosine A2A agonist CGS 21680 affect effort-related choice behavior in rats.

Authors:  Laura Font; Susana Mingote; Andrew M Farrar; Mariana Pereira; Lila Worden; Colin Stopper; Russell G Port; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2008-05-20       Impact factor: 4.530

Review 10.  Neuroanatomy and neurochemistry of sleep.

Authors:  D Stenberg
Journal:  Cell Mol Life Sci       Date:  2007-05       Impact factor: 9.261

View more
  53 in total

1.  Adenosine A2A receptors in the nucleus accumbens bi-directionally alter cocaine seeking in rats.

Authors:  Casey E O'Neill; McKenzie L LeTendre; Ryan K Bachtell
Journal:  Neuropsychopharmacology       Date:  2011-12-14       Impact factor: 7.853

2.  Caffeine increases psychomotor performance on the effort expenditure for rewards task.

Authors:  Margaret C Wardle; Michael T Treadway; Harriet de Wit
Journal:  Pharmacol Biochem Behav       Date:  2012-06-29       Impact factor: 3.533

Review 3.  The ventral pallidum: Subregion-specific functional anatomy and roles in motivated behaviors.

Authors:  David H Root; Roberto I Melendez; Laszlo Zaborszky; T Celeste Napier
Journal:  Prog Neurobiol       Date:  2015-04-06       Impact factor: 11.685

4.  Assessment of a glycine uptake inhibitor in animal models of effort-related choice behavior: implications for motivational dysfunctions.

Authors:  Samantha E Yohn; Daniela Alberati; Merce Correa; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2017-01-12       Impact factor: 4.530

Review 5.  The behavioral pharmacology of effort-related choice behavior: dopamine, adenosine and beyond.

Authors:  John D Salamone; Merce Correa; Eric J Nunes; Patrick A Randall; Marta Pardo
Journal:  J Exp Anal Behav       Date:  2012-01       Impact factor: 2.468

6.  Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism.

Authors:  John D Salamone; Andrew M Farrar; Laura Font; Vatsal Patel; Devra E Schlar; Eric J Nunes; Lyndsey E Collins; Thomas N Sager
Journal:  Behav Brain Res       Date:  2009-03-03       Impact factor: 3.332

7.  The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonists.

Authors:  Lila T Worden; Mona Shahriari; Andrew M Farrar; Kelly S Sink; Jörg Hockemeyer; Christa E Müller; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2008-12-02       Impact factor: 4.530

Review 8.  Dopamine/adenosine interactions involved in effort-related aspects of food motivation.

Authors:  John D Salamone; Merce Correa
Journal:  Appetite       Date:  2009-07-25       Impact factor: 3.868

Review 9.  Effects of Prior Cognitive Exertion on Physical Performance: A Systematic Review and Meta-analysis.

Authors:  Denver M Y Brown; Jeffrey D Graham; Kira I Innes; Sheereen Harris; Ashley Flemington; Steven R Bray
Journal:  Sports Med       Date:  2020-03       Impact factor: 11.136

Review 10.  Effort cost computation in schizophrenia: a commentary on the recent literature.

Authors:  James M Gold; James A Waltz; Michael J Frank
Journal:  Biol Psychiatry       Date:  2015-05-11       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.